title: Reduced NO accumulation in arthrotic cartilage by exposure to methylene blue.
abstract: Nitric oxide (NO) appears to be a final common inflammation mediator of cartilage degradation. Halting the pathological formation of excessive NO, by suppressing the inducible NO synthase (iNOS) activity, may help to preserve cartilage integrity. We used fresh ex-vivo human articular cartilage explants from normal and arthrotic joints for assessment of NO levels, as determined by its nitrite degradation products and nitric oxide synthase expression. We measured matrix proteoglycan content, assessed by image analysis of alcian blue staining, and proteoglycan synthesis, assessed by sulfate incorporation into proteoglycans. The effect of methylene blue, a nitric oxide synthase inhibitor, on matrix preservation was evaluated. Cartilage discs in vitro, derived from normal appearing joints, secreted about one tenth as much NO compared to discs derived from arthrotic cartilage. Cartilage explants showed a time-dependent reduction in the amount of aggrecan within the cartilaginous matrix. Addition of methylene blue to the growth medium lowered nitric oxide accumulation and prevented matrix degradation in the cultured cartilage discs. The cartilage matrix preservation effect was mediated through downregulation of all three isoforms of NOS, i.e., the neuronal NOS, endothelial NOS and inducible NOS and upregulation of TGF beta receptor in the chondrocytes. Our findings indicate that inhibition of NOS activity preserves cartilage matrix in vitro.
authors.affiliation: Department of Clinical Biochemistry, Sackler School of Medicine, Tel-Aviv University, Ramat-Aviv, Israel.
authors.forename: N
authors.initials: N
authors.lastname: Cohen
authors.forename: D
authors.initials: D
authors.lastname: Robinson
authors.forename: J
authors.initials: J
authors.lastname: Ben-Ezzer
authors.forename: Y
authors.initials: Y
authors.lastname: Hemo
authors.forename: A
authors.initials: A
authors.lastname: Hasharoni
authors.forename: Y
authors.initials: Y
authors.lastname: Wolmann
authors.forename: I
authors.initials: I
authors.lastname: Otremski
authors.forename: Z
authors.initials: Z
authors.lastname: Nevo
mesh_terms: D002358:Cartilage, Articular / Q000378:metabolism*; D006801:Humans; D008751:Methylene Blue; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000378:metabolism*; D052248:Nitric Oxide Synthase Type I; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; D015207:Osteoarthritis, Hip / Q000378:metabolism*; D020370:Osteoarthritis, Knee / Q000378:metabolism*; D018125:Receptors, Transforming Growth Factor beta / Q000378:metabolism
chemical_list: D018125:Receptors, Transforming Growth Factor beta; D009569:Nitric Oxide; C496320:NOS1 protein, human; C496319:NOS2 protein, human; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; D008751:Methylene Blue